Pelthos Therapeutics Inc. /
Biofrontera Inc.
Pelthos Therapeutics Inc. agrees to buy Biofrontera Inc.
Source for the buyer and target: Biofrontera Inc.
For the buyer and target.
“On November 6, 2025 (the “ Closing Date ”), Biofrontera Inc. (the “ Company ”) entered into an Asset Purchase Agreement (the “ APA ”) with Pelthos Therapeutics Inc. (the “ Purchaser ”), an unaffiliated party, providing for the sale of all of the assets relating to the Company’s product, Xepi® (ozenoxacin) cream (the “ Transaction ”).”
Published 7 Nov 2025
Open the sourceWhat happened
Pelthos Therapeutics Inc. agreed to acquire Biofrontera Inc., according to a filing dated Nov. 7, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Pelthos Therapeutics Inc. agrees to buy Biofrontera Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Pelthos Therapeutics Inc. agrees to buy Biofrontera Inc. Pelthos Therapeutics Inc. agreed to acquire Biofrontera Inc., according to a filing dated Nov. 7, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly